Table 2.

Brain metastases across melanoma subtypes.

	CM	UM	MM	AM
Incidence of BM in metastatic patients	40-60% (36)	6.3%	20-50% (37)	30% (38)
Incidence of BM on initial metastatic diagnosis	30-40% (39)	12.9%	9.2% (40)	Unknown
mOS from BM diagnosis (months)	4-6 (41, 42)	7.6	Unknown	Unknown
Most common initial site of metastasis	Lymph node	Liver	Lymph node	Lymph node

Table 2 compares the pattern of brain metastases and initial metastases across different melanoma subtypes. CM, cutaneous melanoma; UM, uveal melanoma; MM, mucosal melanoma; AM, acral melanoma.